Page last updated: 2024-09-03

ly 255283 and calcimycin

ly 255283 has been researched along with calcimycin in 1 studies

Compound Research Comparison

Studies (ly 255283)	Trials (ly 255283)	Recent Studies (post-2010) (ly 255283)	Studies (calcimycin)	Trials (calcimycin)	Recent Studies (post-2010) (calcimycin)
54	0	15	11,946	40	444

Protein Interaction Comparison

Protein	Taxonomy	ly 255283 (IC50)	calcimycin (IC50)
XBP1	Homo sapiens (human)		1.41
DNA damage-inducible transcript 3 protein	Mus musculus (house mouse)		0.16

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Au, BT; Collins, PD; Williams, TJ	1

Other Studies

1 other study(ies) available for ly 255283 and calcimycin

Article	Year
Zymosan-induced IL-8 release from human neutrophils involves activation via the CD11b/CD18 receptor and endogenous platelet-activating factor as an autocrine modulator. Journal of immunology (Baltimore, Md. : 1950), 1994, Jun-01, Volume: 152, Issue:11 Topics: Antibodies, Monoclonal; Calcimycin; CD18 Antigens; Humans; Integrins; Interleukin 1 Receptor Antagonist Protein; Interleukin-8; Macrophage-1 Antigen; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Platelet Activating Factor; Sialoglycoproteins; Tetrazoles; Tumor Necrosis Factor-alpha; Zymosan	1994

Article

Year

Zymosan-induced IL-8 release from human neutrophils involves activation via the CD11b/CD18 receptor and endogenous platelet-activating factor as an autocrine modulator.

Journal of immunology (Baltimore, Md. : 1950), 1994, Jun-01, Volume: 152, Issue:11

Topics: Antibodies, Monoclonal; Calcimycin; CD18 Antigens; Humans; Integrins; Interleukin 1 Receptor Antagonist Protein; Interleukin-8; Macrophage-1 Antigen; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Platelet Activating Factor; Sialoglycoproteins; Tetrazoles; Tumor Necrosis Factor-alpha; Zymosan

1994